Octapharma wins FDA approval for drug to urgently reverse effects of blood thinners
The FDA approved a new treatment option for adult patients who need an urgent reversal of blood thinners such as warfarin.
Octapharma’s Balfaxar is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
